The FDA Just Cleared a New Technology That Can Rival a Facelift Without Surgery
Cytrellis just received the green light for the device, which it’s named the ellacor system with Micro-Coring technology, and will be marketing as a minimally invasive method for reducing moderate-to-severe wrinkles in the mid and lower face.
Read MoreCytrellis Announces FDA Clearance for Breakthrough ellacor™ Micro-Coring™ Technology
Cytrellis announced that the U.S. Food and Drug Administration has cleared their first proprietary product, the ellacor system with Micro-Coring technology, for the treatment of moderate to severe wrinkles in the mid to lower face.
Read MoreCytrellis Named A Finalist In Prestigious Innovation Competition
Cytrellis was named a finalist in the prestigious Terra2 Solutions Skin Health Innovation Competition at the Winter Clinical Dermatology Conference Jan 16-24! The competition is for companies developing game-changing technologies for skin health.
Read More“Women In Aesthetics” series is featuring Karen Cronholm, President and CEO of Cytrellis.
As seen in Modern Aesthetics
Industry veteran Wendy Lewis sat down with Karen Cronholm to find out what she has learned along her path to CEO of an emerging aesthetics company. They discuss Karen’s start in the aesthetics field, her mentors, advice for the industry’s rising stars and much more.
Read MoreCytrellis Recognized as Finalist for Prestigious Innovation of the Year Award
Cytrellis competed in “Innovation Shark Tank” during IMCAS’ Global Market Summit, and was named first runner-up for IMCAS Innovation of the Year and awarded IMCAS Promising Innovation 2020!
Read MoreTop Aesthetic Trends to Expect in 2020, According to Dermatologists and Plastic Surgeons
As seen in NewBeauty
New York dermatologist Doris Day, MD calls the fractional facelift the “most exciting and revolutionary of all of the new rejuvenation technology….ever!” According to Dr. Day, the treatment relies on micro-coring of skin—a technique where “anywhere from dozens to hundreds of tiny, full thickness cores of the skin are removed”—which leaves bridges of normal skin between them, “allowing for skin contraction and a veritable lift, without surgery and with very little downtime.”
Read MoreNovel dermal micro-coring device holds promise for moderate to severe wrinkle
As seen in Dermatology News
An investigative dermal micro-coring device designed for improvement of moderate to severe facial wrinkles and tightening is poised to become a game-changer in the minimally invasive aesthetics field…
Read MoreThe New Non-Surgical Facelift: Can Dermal Micro-Coring Come Close to Surgery?
The Next 25 Years in Beauty
As seen in Marie Claire
“In 2 years, you won’t need surgery to give your face a lift”… The Cytrellis treatment “is like a facelift by a thousand small cuts instead of a few big ones, but there’s no scarring and the results are subtler,” says Dr. Mathew Avram, faculty director of the Dermatology Laser and Cosmetic Center at Massachusetts General Hospital. “Trials are underway now.”
Read MoreCytrellis Completes $28.5 Million Series B Financing
Cytrellis announced today that it has received $28.5 million in a Series B round which included existing investors ARCH Venture Partners, the Merz Venture Initiative and new investors, Partner Fund Management and Biomatics Captial.
Read More